114 related articles for article (PubMed ID: 15691310)
1. Amoxicillin resistance in Helicobacter pylori: studies from Tokyo, Japan from 1985 to 2003.
Watanabe K; Tanaka A; Imase K; Tokunaga K; Sugano H; Kai A; Ishida H; Itoh T; Takahashi S
Helicobacter; 2005 Feb; 10(1):4-11. PubMed ID: 15691310
[TBL] [Abstract][Full Text] [Related]
2. Trends of second-line eradication therapy for Helicobacter pylori in Japan: a multicenter study in the Tokyo metropolitan area.
Asaoka D; Nagahara A; Matsuhisa T; Takahashi S; Tokunaga K; Kawai T; Kawakami K; Suzuki H; Suzuki M; Nishizawa T; Kurihara N; Ito M; Sasaki H; Omata F; Mizuno S; Torii A; Ohkusa T; Mine T; Sakaki N
Helicobacter; 2013 Dec; 18(6):468-72. PubMed ID: 23773231
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
[TBL] [Abstract][Full Text] [Related]
4. Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan.
Hoshiya S; Watanabe K; Tokunaga K; Tanaka A; Ninomiya H; Shingaki M; Itoh T; Saito S; Ishida H; Takahashi S
J Gastroenterol; 2000; 35(1):10-4. PubMed ID: 10632534
[TBL] [Abstract][Full Text] [Related]
5. [Antibiotic-resistant H. pylori strains in the last ten years in Japan].
Murakami K; Kimoto M
Nihon Rinsho; 1999 Jan; 57(1):81-6. PubMed ID: 10036940
[TBL] [Abstract][Full Text] [Related]
6. [Importance of drug selection and the use of sensitivity tests for the eradication therapy for Helicobacter pylori].
Sakurai K; Takahashi H; Yamaguchi Y; Yamada M; Kirihara K; Kojima T; Fujita R
Nihon Rinsho; 1999 Jan; 57(1):72-5. PubMed ID: 10036938
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a triple therapy with rabeprazole, amoxicillin, and faropenem as second-line treatment after failure of initial Helicobacter pylori eradication therapy.
Togawa J; Inamori M; Fujisawa N; Takahashi H; Yoneda M; Kawamura H; Abe Y; Kirikoshi H; Kobayashi N; Sakaguchi T; Takamura T; Nakajima A; Ueno N; Sekihara H
Hepatogastroenterology; 2005; 52(62):645-8. PubMed ID: 15816496
[TBL] [Abstract][Full Text] [Related]
8. [Sensitivity of Helicobacter pylori to amoxicillin and clarythromycin with special reference to eradication therapy].
Tsuneoka H; Takaba M; Nagatomi Y; Mori K; Matsumoto T; Honda T
Kansenshogaku Zasshi; 1998 Apr; 72(4):335-41. PubMed ID: 9621560
[TBL] [Abstract][Full Text] [Related]
9. [Selection of antibiotics and planning of eradication for H. pylori infection].
Murakami K; Satoh R; Okimoto T; Kagawa J; Fujioka T; Kodama M
Nihon Rinsho; 2001 Feb; 59(2):308-13. PubMed ID: 11218403
[TBL] [Abstract][Full Text] [Related]
10. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.
Marzio L; Coraggio D; Capodicasa S; Grossi L; Cappello G
Helicobacter; 2006 Aug; 11(4):237-42. PubMed ID: 16882326
[TBL] [Abstract][Full Text] [Related]
11. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
[TBL] [Abstract][Full Text] [Related]
12. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT
J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862
[TBL] [Abstract][Full Text] [Related]
13. Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border.
Cardenas VM; Graham DY; El-Zimaity HM; Opekun AR; Campos A; Chavez A; Guerrero L
Aliment Pharmacol Ther; 2006 Jan; 23(2):295-301. PubMed ID: 16393310
[TBL] [Abstract][Full Text] [Related]
14. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
15. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
16. Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance.
Nguyen TV; Bengtsson C; Yin L; Nguyen GK; Hoang TT; Phung DC; Sörberg M; Granström M
Helicobacter; 2012 Aug; 17(4):319-25. PubMed ID: 22759333
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection.
Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Fujioka T; Kodama M; Abe T; Sato S; Arita T
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):262-7. PubMed ID: 16460484
[TBL] [Abstract][Full Text] [Related]
18. Duration of the metronidazole-containing regimen for eradication of Helicobacter pylori infection in northern Japan.
Fukuda S; Shimoyama T; Tanaka M; Nakasato F; Fukushi M; Munakata A
Jpn J Infect Dis; 2006 Dec; 59(6):367-9. PubMed ID: 17186954
[TBL] [Abstract][Full Text] [Related]
19. Update on clarithromycin resistance in Helicobacter pylori in Hong Kong and its effect on clarithromycin-based triple therapy.
Gu Q; Xia HH; Wang JD; Wong WM; Chan AO; Lai KC; Chan CK; Yuen MF; Fung FM; Wong KW; Lam SK; Wong BC
Digestion; 2006; 73(2-3):101-6. PubMed ID: 16788304
[TBL] [Abstract][Full Text] [Related]
20. [The cause of failure of eradication treatment of Helicobacter pylori].
Chen G; Takeuchi Y; Kikuchi R; Arai D; Fukuchi K; Gomi K
Rinsho Byori; 2005 Aug; 53(8):692-7. PubMed ID: 16190353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
